Sarecycline interferes with tRNA accommodation and tethers mRNA to the 70S ribosome
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Significance: Sarecycline is the first narrow-spectrum tetracycline-class antibiotic that was recently approved by the FDA for the clinical treatment of acne vulgaris. In this work, we determined two (2.8-Å and 3.0-Å) X-ray crystal structures of sarecycline bound to the initiation complex of the bacterial 70S ribosome and found that this antibiotic inhibits bacterial ribosome in part using a mechanism of direct mRNA contact, which has not been reported for any other tetracyclines so far. Moreover, our structural analysis rationalizes why sarecycline is able to overcome one of the most common mechanisms of resistance to tetracyclines among pathogenic bacteria. Thus, this work provides mechanistic insights into the function of the tetracycline class of antibiotics on the ribosome with direct clinical relevance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, recent studies indicate that species specific differences in the architecture of the 70S ribosomes from pathogenic bacteria like C. acnes can influence the antibiotic binding and mechanism of action12,20.”
From Dual site targeting of the bacterial 70S ribosome by tetracyclines (2026) · cites this paper as [20]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
PRODRG: a tool for high-throughput crystallography of protein–ligand complexes
Schüttelkopf, A. W., & van Aalten, D. M. F. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904011679 · Cited by 4,804
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517 · cited 1×
“Many of the tetracyclines that are in clinical use today carry chemical moieties that endow them with activity against tetracycline-resistant bacterial strains (12).”
BackgroundRibosome-targeting antibiotics and mechanisms of bacterial resistance
Wilson, D. N. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3155 · Cited by 1,054 · cited 1×
“B protein synthesis is targeted and inhibited by many small-molecule compounds (1).”
BackgroundBrodersen, D. E., Clemons, W. M., Carter, A. P., Morgan-Warren, R. J., Wimberly, B. T., & Ramakrishnan, V. (2000) · Cell · doi:10.1016/s0092-8674(00)00216-6 · Cited by 950 · cited 2×
“For example, in the previously reported structures of ribosome-bound TET or TIG, there is a complete absence of electron density for the mRNA in the A site (2, 13).”
BackgroundMethodTetracycline antibiotics and resistance mechanisms
Nguyen, F., Starosta, A. L., Arenz, S., Sohmen, D., Dönhöfer, A., & Wilson, D. N. (2014) · Biological Chemistry · doi:10.1515/hsz-2013-0292 · Cited by 528
Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3
Pioletti, M., Schlünzen, F., Harms, J., Zarivach, R., Glühmann, M., Avila, H., Bashan, A., Bartels, H., Auerbach, T., Jacobi, C., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1829 · Cited by 527 · cited 1×
“Although in our cocrystallization experiments we used higher concentrations of the drug (500 μM) than those used previously for structural studies of TET and its derivatives (4–80 μM), we observed SAR binding only at the primary tetracycline binding site and not at any of the secondary tetracycline binding sites repor…”
MethodtRNA selection and kinetic proofreading in translation
Blanchard, S. C., Gonzalez, R. L., Kim, H. D., Chu, S., & Puglisi, J. D. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb831 · Cited by 466 · cited 2×
“This is in contrast to the proposed previously general mechanism of action of tetracyclines that implies that these drugs can act equally well at each elongation cycle (13, 17, 26).”
BackgroundResultRibosomal Protection Proteins and Their Mechanism ofTetracyclineResistance
Connell, S. R., Tracz, D. M., Nierhaus, K. H., & Taylor, D. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3675-3681.2003 · Cited by 449 · cited 2×
“Many bacteria acquire tetracycline resistance via ribosome protection proteins, such as TetM and TetO, which are paralogues of EF-G (9).”
BackgroundGriffin, M. O., Fricovsky, E., Ceballos, G., & Villarreal, F. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00047.2010 · Cited by 413
Lin, J., Zhou, D., Steitz, T. A., Polikanov, Y. S., & Gagnon, M. G. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-011942 · Cited by 405
Self-citation[27] Extension inhibition analysis of translation initiation complexes
Hartz, D., McPheeters, D. S., Traut, R., & Gold, L. (1988) · Methods in Enzymology · doi:10.1016/s0076-6879(88)64058-4 · Cited by 397
Structural insights into the role of rRNA modifications in protein synthesis and ribosome assembly
Polikanov, Y. S., Melnikov, S. V., Söll, D., & Steitz, T. A. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2992 · Cited by 272
Self-citationMolecular Mechanism of Drug-Dependent Ribosome Stalling
Vazquez-Laslop, N., Thum, C., & Mankin, A. S. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.02.026 · Cited by 260
Structural basis for TetM-mediated tetracycline resistance
Dönhöfer, A., Franckenberg, S., Wickles, S., Berninghausen, O., Beckmann, R., & Wilson, D. N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208037109 · Cited by 217
Jenner, L., Starosta, A. L., Terry, D. S., Mikolajka, A., Filonava, L., Yusupov, M., Blanchard, S. C., Wilson, D. N., & Yusupova, G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216691110 · Cited by 204 · cited 4×
“For example, in the previously reported structures of ribosome-bound TET or TIG, there is a complete absence of electron density for the mRNA in the A site (2, 13).”
BackgroundResultInfluentialRetapamulin-Assisted Ribosome Profiling Reveals the Alternative Bacterial Proteome
Meydan, S., Marks, J., Klepacki, D., Sharma, V., Baranov, P. V., Firth, A. E., Margus, T., Kefi, A., Vázquez-Laslop, N., & Mankin, A. S. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.02.017 · Cited by 184
Marks, J., Kannan, K., Roncase, E. J., Klepacki, D., Kefi, A., Orelle, C., Vázquez-Laslop, N., & Mankin, A. S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613055113 · Cited by 159
Odilorhabdins, Antibacterial Agents that Cause Miscoding by Binding at a New Ribosomal Site
Pantel, L., Florin, T., Dobosz-Bartoszek, M., Racine, E., Sarciaux, M., Serri, M., Houard, J., Campagne, J., de Figueiredo, R. M., Midrier, C., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.03.001 · Cited by 156
Self-citationMechanism of tetracycline resistance by ribosomal protection protein Tet(O)
Li, W., Atkinson, G. C., Thakor, N. S., Allas, Ü., Lu, C.-C., Chan, K.-Y., Tenson, T., Schulten, K., Wilson, K. S., Hauryliuk, V., et al. (2013) · Nature Communications · doi:10.1038/ncomms2470 · Cited by 147 · cited 1×
“Resistance to tetracyclines can be mediated either by the drug efflux pumps (9) or by the special ribosome protecting proteins (such as TetO/TetM) that resemble translation elongation factor G and induce conformational changes in the drug-binding pocket that prevent rebinding of the antibiotic (10, 11).”
Tools for Characterizing Bacterial Protein Synthesis Inhibitors
Orelle, C., Carlson, S., Kaushal, B., Almutairi, M. M., Liu, H., Ochabowicz, A., Quan, S., Pham, V. C., Squires, C. L., Murphy, B. T., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01673-13 · Cited by 124
Context-Specific Action of Ribosomal Antibiotics
Vázquez-Laslop, N., & Mankin, A. S. (2018) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090817-062329 · Cited by 83
Antibacterial Therapy for Acne: A Guide to Selection and Use of Systemic Agents
Tan, H. H. (2003) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200304050-00002 · Cited by 82
Zhanel, G., Critchley, I., Lin, L.-Y., & Alvandi, N. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01297-18 · Cited by 77
Comprehensive identification of translation start sites by tetracycline-inhibited ribosome profiling
Nakahigashi, K., Takai, Y., Kimura, M., Abe, N., Nakayashiki, T., Shiwa, Y., Yoshikawa, H., Wanner, B. L., Ishihama, Y., & Mori, H. (2016) · DNA Research · doi:10.1093/dnares/dsw008 · Cited by 73
Svetlov, M. S., Plessa, E., Chen, C.-W., Bougas, A., Krokidis, M. G., Dinos, G. P., & Polikanov, Y. S. (2019) · RNA · doi:10.1261/rna.069260.118 · Cited by 72
Self-citationArenz, S., Nguyen, F., Beckmann, R., & Wilson, D. N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501775112 · Cited by 68
(2018) · PubMed · Cited by 65
WEBSTER, G. F., McGINLEY, K. J., & LEYDEN, J. J. (1981) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1981.tb15317.x · Cited by 60
Negamycin interferes with decoding and translocation by simultaneous interaction with rRNA and tRNA
Polikanov, Y. S., Szal, T., Jiang, F., Gupta, P., Matsuda, R., Shiozuka, M., Steitz, T. A., Vázquez-Laslop, N., & Mankin, A. S. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.021 · Cited by 57 · cited 2×
“Because binding of the drug can occur at each elongation cycle, the resulting toe-printing pattern consists of multiple toe-printing bands separated by one codon (three nucleotides)—a pattern that is referred in the literature as ribosome stuttering (17, 18, 27).”
BackgroundResultSelf-citationProbing Translation with Small-Molecule Inhibitors
Blanchard, S. C., Cooperman, B. S., & Wilson, D. N. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.06.003 · Cited by 51
Competition between tetracycline and tRNA at both P and A sites of the ribosome of Escherichia coli
Epe, B., Woolley, P., & Hornig, H. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)81539-9 · Cited by 50
Sarecycline: First Global Approval
Deeks, E. D. (2019) · Drugs · doi:10.1007/s40265-019-1053-4 · Cited by 44
Kinetic aspects of tetracycline action on the acceptor (A) site of Escherichia coli ribosomes
Semenkov, Y. P., Makarov, E. M., Makhno, V. I., & KIRILLOV, S. V. (1982) · FEBS Letters · doi:10.1016/0014-5793(82)80584-x · Cited by 41
WURMBACH, P., & NIERHAUS, K. H. (1983) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1983.tb07109.x · Cited by 27
Pichkur, E., Paleskava, A., Tereshchenkov, A. G., Kasatsky, P. S., Komarova, E. S., Shiriaev, D. I., Bogdanov, A. A., Dontsova, O. А., Osterman, I. А., Владимирович, С. П., et al. (2020) · RNA · doi:10.1261/rna.073817.119 · Cited by 23
Self-citationKhabibullina, N. F., Tereshchenkov, A. G., Komarova, E. S., Syroegin, E. A., Shiriaev, D. I., Paleskava, A., Kartsev, V. G., Bogdanov, A. A., Konevega, A. L., Dontsova, O. А., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02266-18 · Cited by 13
Self-citationKhabibullina, N. F., Tereshchenkov, A. G., Komarova, E. S., Syroegin, E. A., Shiriaev, D. I., Paleskava, A., Kartsev, V. G., Bogdanov, A. A., Konevega, A. L., Dontsova, O. А., et al. (2019) · Worldwide Protein Data Bank · doi:10.2210/pdb6of1/pdb · Cited by 9
Self-citation
Cited by
Antibiotics and Bacterial Resistance—A Short Story of an Endless Arms Race
Baran, A., Kwiatkowska, A., & Potocki, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065777 · Cited by 300
The Development of Third-Generation Tetracycline Antibiotics and New Perspectives
Rusu, A., & Buta, E. L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122085 · Cited by 210
Tetracyclines and bone: Unclear actions with potentially lasting effects
Warner, A. J., Hathaway‐Schrader, J. D., Lubker, I. M., Davies, C., & Novince, C. M. (2022) · Bone · doi:10.1016/j.bone.2022.116377 · Cited by 114
Shi, Z., Zhang, J., Tian, L., Xin, L., Liang, C., Ren, X., & Li, M. (2023) · Molecules · doi:10.3390/molecules28041762 · Cited by 110
Treating acne with the tetracycline class of antibiotics: A review
Graber, E. (2021) · Dermatological Reviews · doi:10.1002/der2.49 · Cited by 67
Metadata
- Authors
- Batool, Z., Lomakin, I. B., Polikanov, Y. S., & Bunick, C. G.
- Affiliations
- University of Illinois Chicago (US)
- Yale University (US)
- Corresponding author
- Polikanov, Yury S.
- Bunick, Christopher G.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2020-08-12
- Volume
- 117
- Issue
- 34
- Pages
- 20530-20537
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC7456112
- OpenAlex
- W3048666621
- Cited by
- 50
- References
- 41
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 7 · 2023: 11 · 2022: 11 · 2021: 9
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Funders
- HHS | National Institutes of Health (K08-AR070290, R21-AI137584, R01-GM132302)
- UofI | University of Illinois at Chicago (Startup Funds)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- sarecycline, tetracycline, 70S ribosome, ribosome structure, decoding center, antibiotic mechanism of action, small ribosomal subunit
- MeSH terms
- Anti-Bacterial Agents, Ribosomes, RNA, Ribosomal, 16S, Tetracyclines, Thermus thermophilus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.